Buscar
01/08/2021
Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal Studies
Papotti, B, Escola-Gil, JC, Julve, J, Poti, F, Zanotti, I. Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal Studies. Nutrients. 2021; 13(8)DOI:10.3390/nu13082643. PMID:34444804. IF:6.706(Q1/2D).
01/08/2021
Special issue: Diet, lipids, and cancer: From Pathogenic mechanisms to potential therapeutic strategies
Farras, M, Escola-Gil, JC. Special issue: Diet, lipids, and cancer: From Pathogenic mechanisms to potential therapeutic strategies. SEMINARS IN CANCER BIOLOGY. 2021; 73DOI:10.1016/j.semcancer.2021.05.015. PMID:34015466. IF:17.012(Q1/1D).
01/07/2021
Y High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future
Julve, J, Escola-Gil, JC. Y High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2021; 22(14)DOI:10.3390/ijms22147488. PMID:34299108. IF:6.208(Q1/3D).
18/01/2023
Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?
Canyelles M., Borràs C., Rotllan N., Tondo M., Escolà-Gil J.C., Blanco-Vaca F.. Gut Microbiota-Derived TMAO: A Causal Factor Promoting Atherosclerotic Cardiovascular Disease?. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(3)DOI:10.3390/ijms24031940. PMID:36768264. IF:4.900(Q1/3D).
01/10/2022
Impact of Phenol-Enriched Olive Oils on Serum Metabonome and Its Relationship with Cardiometabolic Parameters: A Randomized, Double-Blind, Cross-Over, Controlled Trial
Farras, M, Swann, JR, Rowland, I, Rubio, L, Subirana, I, Catalan, U, Motilva, MJ, Sola, R, Covas, MI, Blanco-Vaca, F, Fito, M, Mayneris-Perxachs, J. Impact of Phenol-Enriched Olive Oils on Serum Metabonome and Its Relationship with Cardiometabolic Parameters: A Randomized, Double-Blind, Cross-Over, Controlled Trial. Antioxidants. 2022; 11(10)DOI:10.3390/antiox11101964. PMID:36290685. IF:7.000(Q1/1D).
01/03/2022
Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm
Roldan-Montero, R, Perez-Saez, JM, Cerro-Pardo, I, Oller, J, Martinez-Lopez, D, Nunez, E, Maller, SM, Gutierrez-Munoz, C, Mendez-Barbero, N, Escola-Gil, JC, Michel, JB, Mittelbrunn, M, Vazquez, J, Blanco-Colio, LM, Rabinovich, GA, Martin-Ventura, JL. Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm. Science Advances. 2022; 8(11)DOI:10.1126/sciadv.abm7322. PMID:35294231. IF:13.600(Q1/1D).
01/03/2022
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II
Julve, J, Escola-Gil, JC. High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II. Biomedicines. 2022; 10(3)DOI:10.3390/biomedicines10030620. PMID:35327422. IF:4.700(Q1/3D).
01/03/2022
The Underlying Pathology of Atherosclerosis: Different Players
Rotllan, N. The Underlying Pathology of Atherosclerosis: Different Players. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(6)DOI:10.3390/ijms23063235. PMID:35328656. IF:5.600(Q1/3D).